222 related articles for article (PubMed ID: 22717603)
1. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells.
Nam S; Xie J; Perkins A; Ma Y; Yang F; Wu J; Wang Y; Xu RZ; Huang W; Horne DA; Jove R
Mol Oncol; 2012 Oct; 6(5):484-93. PubMed ID: 22717603
[TBL] [Abstract][Full Text] [Related]
2. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
Yang F; Nam S; Zhao R; Tian Y; Liu L; Horne DA; Jove R
Cancer Biol Ther; 2013 Nov; 14(11):1024-31. PubMed ID: 24025361
[TBL] [Abstract][Full Text] [Related]
3. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
5. A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling.
Liu L; Kritsanida M; Magiatis P; Gaboriaud N; Wang Y; Wu J; Buettner R; Yang F; Nam S; Skaltsounis L; Jove R
Cancer Biol Ther; 2012 Nov; 13(13):1255-61. PubMed ID: 22895078
[TBL] [Abstract][Full Text] [Related]
6. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
[TBL] [Abstract][Full Text] [Related]
7. A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells.
Wu KJ; Huang JM; Zhong HJ; Dong ZZ; Vellaisamy K; Lu JJ; Chen XP; Chiu P; Kwong DWJ; Han QB; Ma DL; Leung CH
PLoS One; 2017; 12(6):e0177123. PubMed ID: 28570563
[TBL] [Abstract][Full Text] [Related]
8. Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.
Tian Y; Nam S; Liu L; Yakushijin F; Yakushijin K; Buettner R; Liang W; Yang F; Ma Y; Horne D; Jove R
PLoS One; 2012; 7(11):e49306. PubMed ID: 23166634
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2/STAT3 signaling pathway in human melanoma cells.
Raut PK; Lee HS; Joo SH; Chun KS
Food Chem Toxicol; 2021 Nov; 157():112604. PubMed ID: 34627931
[TBL] [Abstract][Full Text] [Related]
10. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
11. Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells.
Zhang HH; Kuang S; Wang Y; Sun XX; Gu Y; Hu LH; Yu Q
Acta Pharmacol Sin; 2015 Apr; 36(4):507-16. PubMed ID: 25619393
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells.
Zhang L; Tong J; He X; Liang Y; Zhu L; Xu R; Zhao X
Ann Hematol; 2018 Dec; 97(12):2353-2362. PubMed ID: 30099568
[TBL] [Abstract][Full Text] [Related]
13. 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells.
Shan H; Yao S; Ye Y; Yu Q
Acta Pharmacol Sin; 2019 Dec; 40(12):1578-1586. PubMed ID: 31201357
[TBL] [Abstract][Full Text] [Related]
14. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.
Wang GY; Lv QH; Dong Q; Xu RZ; Dong QH
J Asian Nat Prod Res; 2009; 11(3):219-28. PubMed ID: 19408145
[TBL] [Abstract][Full Text] [Related]
15. Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling.
Yang N; Han F; Cui H; Huang J; Wang T; Zhou Y; Zhou J
Pharmacol Rep; 2015 Apr; 67(2):388-93. PubMed ID: 25712669
[TBL] [Abstract][Full Text] [Related]
16. Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.
Bill MA; Nicholas C; Mace TA; Etter JP; Li C; Schwartz EB; Fuchs JR; Young GS; Lin L; Lin J; He L; Phelps M; Li PK; Lesinski GB
PLoS One; 2012; 7(8):e40724. PubMed ID: 22899991
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells.
Nam S; Wen W; Schroeder A; Herrmann A; Yu H; Cheng X; Merz KH; Eisenbrand G; Li H; Yuan YC; Jove R
Mol Oncol; 2013 Jun; 7(3):369-78. PubMed ID: 23206899
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2/STAT3/BCL-xL signaling axis.
Kuo MY; Dai WC; Chang JL; Chang JS; Lee TM; Chang CC
Environ Toxicol; 2024 Jun; 39(6):3356-3366. PubMed ID: 38444163
[TBL] [Abstract][Full Text] [Related]
19. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q
Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767
[TBL] [Abstract][Full Text] [Related]
20. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
Huang H; Niu J; Wang F; Hu L; Yu Q
Invest New Drugs; 2019 Jun; 37(3):452-460. PubMed ID: 30073465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
